CRIS Current Research Information System

FERRACIN, MANUELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.194
EU - Europa 4.533
AS - Asia 1.425
AF - Africa 231
Continente sconosciuto - Info sul continente non disponibili 61
SA - Sud America 25
OC - Oceania 5
Totale 12.474
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.165
IT - Italia 1.255
GB - Regno Unito 1.107
CN - Cina 631
DE - Germania 580
SE - Svezia 505
VN - Vietnam 361
IN - India 268
IE - Irlanda 194
RU - Federazione Russa 193
FR - Francia 161
ZA - Sudafrica 111
EE - Estonia 104
UA - Ucraina 96
CH - Svizzera 86
HR - Croazia 86
TG - Togo 64
EU - Europa 61
FI - Finlandia 42
JO - Giordania 42
BG - Bulgaria 41
CI - Costa d'Avorio 39
PK - Pakistan 39
CA - Canada 26
GR - Grecia 19
IR - Iran 19
HK - Hong Kong 15
BE - Belgio 13
SG - Singapore 12
BR - Brasile 11
ES - Italia 11
NG - Nigeria 9
NL - Olanda 9
CL - Cile 8
TR - Turchia 8
JP - Giappone 6
RO - Romania 6
SC - Seychelles 6
AT - Austria 5
AU - Australia 5
LB - Libano 5
PL - Polonia 4
UZ - Uzbekistan 4
BD - Bangladesh 3
DK - Danimarca 3
KR - Corea 3
MX - Messico 3
PE - Perù 3
SI - Slovenia 3
SM - San Marino 3
CZ - Repubblica Ceca 2
EG - Egitto 2
NO - Norvegia 2
PH - Filippine 2
RS - Serbia 2
TH - Thailandia 2
AR - Argentina 1
AZ - Azerbaigian 1
BO - Bolivia 1
ID - Indonesia 1
IL - Israele 1
KH - Cambogia 1
LV - Lettonia 1
SA - Arabia Saudita 1
UY - Uruguay 1
Totale 12.474
Salva come PNG Salva come JPEG
Città #
Fairfield 1.095
Southend 1.005
Ashburn 516
Houston 480
Woodbridge 471
Seattle 449
Chandler 437
Wilmington 385
Cambridge 373
Bologna 340
Ann Arbor 330
Princeton 295
Dong Ket 217
Dublin 194
Nanjing 124
Berlin 123
Westminster 118
Padova 101
Bern 72
Beijing 64
Jinan 64
Lomé 64
San Diego 61
Saint Petersburg 59
Shenyang 56
Milan 55
Hebei 50
Olalla 46
Redmond 45
Amman 42
Sofia 41
Abidjan 39
New York 38
Rome 36
Helsinki 35
Des Moines 34
Nanchang 34
Reggio Emilia 31
Bremen 30
Changsha 30
Falls Church 30
Norwalk 28
Tianjin 26
Turin 25
Jacksonville 24
London 24
Florence 22
Jiaxing 22
Zhengzhou 22
Hangzhou 19
Vicenza 19
Ferrara 18
Toronto 18
Parma 16
Correggio 15
Palermo 15
Redwood City 15
Taiyuan 15
Boydton 14
Bühl 14
Dearborn 14
Hong Kong 14
Boardman 13
Haikou 13
Lanzhou 13
Los Angeles 13
Centro 11
Guangzhou 11
Medford 11
Mülheim 11
Ningbo 11
Paris 11
Taizhou 11
Brussels 10
Formigine 10
Abeokuta 9
Chicago 9
Phoenix 9
Tehran 9
Islamabad 8
Kuban 8
Buffalo 7
Lahore 7
Lappeenranta 7
Verona 7
Bari 6
Crocetta 6
Naples 6
Ravenna 6
Trieste 6
Washington 6
Costa Volpino 5
Frankfurt Am Main 5
Giacciano con Baruchella 5
Hyderabad 5
Istanbul 5
Lausanne 5
Madrid 5
Pavia 5
Pune 5
Totale 8.818
Salva come PNG Salva come JPEG
Nome #
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations 209
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 186
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 165
Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations 146
Cancer of unknown primary: Challenges and progress in clinical management 139
Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR 137
Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians 137
LncRNAs as novel players in hepatocellular carcinoma recurrence 135
Basal cell carcinoma: A comprehensive review 134
ARID1A in cancer: Friend or foe? 131
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. 131
Cancer site-specific multiple microRNA quantification by droplet digital PCR 131
Identification of miRNAs differentially expressed in human epilepsy with or without granule cell pathology 129
BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients 129
Oncogenic role of miR-483-3p at the IGF2/483 locus. 122
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 122
Epigenetic and epitranscriptomic changes in colorectal cancer: diagnostic, prognostic, and treatment implications 119
Serum from Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells 119
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 117
Heterotopic auxiliary segment 2–3 liver transplantation with delayed total hepatectomy: New strategies for nonresectable colorectal liver metastases 116
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma. 115
Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors 115
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer 115
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers 114
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 113
Circulating non-coding RNA as biomarkers in colorectal cancer 113
MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. 110
Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation 108
Absolute quantification of cell-free microRNAs in cancer patients 107
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. 105
Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule. 105
Involvement of the inconstant bursa of the fifth metatarsophalangeal joint in psoriatic arthritis: A clinical and ultrasonographic study 105
MicroRNA profile in gastrointestinal stromal tumors (GISTs) and correlation with KIT/PDGFRA kinase genotype. 105
Altered miRNA expression in T regulatory cells in course of multiple sclerosis. 105
Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types 105
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 103
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy 103
Quantification of Circulating miRNAs by Droplet Digital PCR: Comparison of EvaGreen- and TaqMan-Based Chemistries. 101
KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC 99
Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches 99
Interplay between small and long non-coding RNAs in cutaneous melanoma: a complex jigsaw puzzle with missing pieces 98
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 97
High Expression of the Sda Synthase B4GALNT2 Associates with Good Prognosis and Attenuates Stemness in Colon Cancer 97
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). 96
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 96
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 95
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. 94
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers 93
miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma 92
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 92
Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. 91
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs 91
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis 90
Essential role of MED1 in the transcriptional regulation of ER-dependent oncogenic miRNAs in breast cancer 90
Quantification of circulating micrornas by droplet digital PCR 89
Estrogen Receptors and Melanoma: A Review 88
Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features 87
STAT3-mediated activation of microRNA cluster 17 92 promotes proliferation and survival of ALK positive anaplastic large cell lymphoma 86
Extensive modulation of a set of microRNAs in primary glioblastoma 84
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 84
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 84
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 83
Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes 83
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia 82
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias 81
miR-15 and miR-16 induce apoptosis by targeting BCL2 80
Non-coding RNAs as predictive biomarkers to current treatment in metastatic colorectal cancer 80
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 80
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 79
Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review 78
Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway. 78
The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma. 78
MicroRNAs as biomarker of Parkinson disease? Small but mighty. 78
The Sda synthase B4GALNT2 reduces malignancy and stemness in colon cancer cell lines independently of sialyl lewis X inhibition 78
MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy - Comparison with human epileptic samples 77
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease 77
Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis 76
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis. 76
Decreased serum levels of the inflammaging marker miR-146a are associated with non-clinical response to tocilizumab in COVID-19 patients 76
A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34(+) progenitors and CML cells 75
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 75
MicroRNA gene expression deregulation in human breast cancer 75
Defining the Prognostic Role of MicroRNAs in Cutaneous Melanoma 75
Micromarkers 2.0: An update on the role of microRNAs in cancer diagnosis and prognosis 74
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. 74
MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer 74
MicroRNAs: toward the clinic for breast cancer patients 74
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 74
OncomiR detection in circulating body fluids: a PDMS microdevice perspective. 73
Familial cancer associated with a polymorphism in ARLTS1 73
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 73
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients. 72
MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer 71
HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts 71
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 71
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 71
Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis 71
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC 69
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab 69
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome 69
Totale 9.756
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.383
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.383
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.616 441 93 7 208 380 368 538 470 496 299 212 104
2020/20212.013 349 116 60 83 45 186 42 126 257 140 75 534
2021/20222.639 242 124 196 190 222 163 96 223 108 193 438 444
2022/20232.518 250 322 122 314 147 174 103 145 430 69 231 211
2023/20241.055 101 144 83 104 76 124 77 71 51 71 75 78
2024/202551 51 0 0 0 0 0 0 0 0 0 0 0
Totale 12.981